Heart disease remains a primary cause of illness and mortality around the world. While ...

Outperformed Approved Pan-HDAC Inhibitor Givinostat in Improving Muscle Function and Correcting Drivers of DMD Cardiomyopathy New Data Confirm TN-301’s Differentiated Mechanism and Opportunities to ...

Weight-loss drugs may prevent deadly heart complications by opening blocked blood vessels after heart attacks, groundbreaking ...

For a heart just damaged by a blocked artery, timing matters. So does access. That is what makes a new experimental treatment ...

A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of ...

Precision BioSciences Inc. (NASDAQ:DTIL) presented new preclinical findings for its PBGENE-DMD gene therapy at the Muscular ...

NOVEL heart failure (HF) research has identified a surprising protective signal produced directly by heart muscle cells that may help slow the development of cardiac fibrosis, a key driver of ...

Heart cookies are a simple yet charming dessert that brings warmth and creativity to home baking. With their soft texture and adorable shape, these cookies are perfect for sharing, gifting, or ...

Human heart cells and tissues grown in the laboratory from stem cells promise to accelerate the development of drugs and treatments for heart disease, but they currently take weeks or months to grow.

A new study suggests that widely used GLP-1 weight-loss drugs may do more than improve metabolic health: they could also protect the heart after a heart attack. Doctors can often reopen the blocked ...

"As we prepare to commence the Phase1/2 FUNCTION-DMD clinical trial for PBGENE-DMD, we're excited to present new preclinical data highlighting its potential to deliver durable, long-term functional ...

A new biotech company forged through an Australian and Danish partnership will accelerate treatments for children and adults with heart disease. Harnessing cellular therapies, the company aims to ...